Kura Oncology, Inc.
KURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $750,462 | $1,053,033 | $831,346 | $928,928 |
| - Cash | $224,462 | $37,318 | $51,802 | $90,672 |
| + Debt | $16,594 | $17,200 | $14,024 | $6,875 |
| Enterprise Value | $542,594 | $1,032,915 | $793,568 | $845,131 |
| Revenue | $53,883 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $53,883 | -$849 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$169,498 | -$150,233 | -$134,852 | -$129,494 |
| % Margin | -314.6% | – | – | – |
| Net Income | -$173,983 | -$152,631 | -$135,840 | -$130,466 |
| % Margin | -322.9% | – | – | – |
| EPS Diluted | -2.02 | -2.08 | -2.03 | -1.97 |
| % Growth | 2.9% | -2.5% | -3% | – |
| Operating Cash Flow | $134,317 | -$124,824 | -$110,062 | -$104,551 |
| Capital Expenditures | -$472 | -$168 | -$626 | -$1,147 |
| Free Cash Flow | $133,845 | -$124,992 | -$110,688 | -$105,698 |